U.S. Markets closed

Tetra Bio-Pharma Inc. (TBP.TO)

Toronto - Toronto Real Time Price. Currency in CAD
Add to watchlist
0.04000.0000 (0.00%)
At close: 03:40PM EDT

Tetra Bio-Pharma Inc.

2316 St. Joseph Boulevard
Orléans, ON K1C 1E8
343 780 2020

Full Time Employees33

Key Executives

NameTitlePayExercisedYear Born
Dr. Guy Chamberland M.Sc., Master HerbalCo-Founder, CEO, Chief Regulatory Officer & Director324.9kN/A1962
Mr. Steeve NéronChief Commercial Officer279kN/AN/A
Mr. André Rancourt B.Sc.Co-FounderN/AN/AN/A
Ms. Leslie Auld CPA, M.B.A.Chief Financial OfficerN/AN/AN/A
Dr. Melanie Edna Mary Kelly Ph.D.Chief Scientific OfficerN/AN/AN/A
Jennifer McCaugheyVP of Investor RelationsN/AN/AN/A
Ms. Dania Scott B.Sc.Sr. VP of Commercial StrategyN/AN/AN/A
Ms. Aurelia De PauwSr. VP of Clinical Programs & Medical AffairsN/AN/AN/A
Mr. Richard GiguereChief Exec. Officer of Tetra Natural Health Inc.N/AN/AN/A
Randy RinguetteProject Director & Member of Advisory BoardN/AN/AN/A
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.


Tetra Bio-Pharma Inc., a biopharmaceutical company, engages in the discovery and development of cannabinoid-derived drugs for inflammation, pain, ophthalmology, and oncology. The company develops PLENITUDE to treat cancer-related pain in advanced cancer patients; REBORN for the treatment of breakthrough cancer pain; Reduvo for chemotherapy-induced nausea and vomiting; ARDS-003 for the treatment of sepsis and prevention of acute respiratory distress syndrome; and SERENITY to treat cancer cachexia. It also develops PPP003 for painful dry eye and uveitis pain; and HCC011 for hepatocellular carcinoma. The company is headquartered in Orléans, Canada.

Corporate Governance

Tetra Bio-Pharma Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.